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 Appendix   Details of input cohorts  Due to space limitations, detailed citations for referenced cohorts were not possible to list in the main text. Here, we reference the input cohort data, which were obtained from: the U.S. National Health and Nutrition Examination Survey (N = 1,441 with diabetes, 2009-2014);1 the U.S. National Institutes of Health Global Health Centres of Excellence surveys from South Africa (N = 1,842 with diabetes, 2012) and India (N = 1,605 with diabetes, 2015);2,3 the South Africa National Health and Nutrition Examination Survey (N = 747 with diabetes, 2012);4 the U.K. National Health Service National Diabetes Audit (N = 16,585 with diabetes, 2016-2017);5 the Indian Jaipur Diabetes Registry (N = 8,699 with diabetes, 2014);6 the Swedish National Diabetes Register (N = 17,827 with diabetes, 2016);7 the Danish Adult Diabetes Registry (N = 11,205 with diabetes, 2014-2015);8 the Turkish Nationwide survey of Glycemic and Other Metabolic Parameters of Patients with Diabetes Mellitus (TEMD study; N = 4,672 with diabetes, 2017);9 the China Health and Nutrition Study (N = 1,422 with diabetes, 1999-2015);10 the DiabCare study of the Philippines (N = 770, 2008);11 the Japan National Health and Nutrition Survey (N = 1434 with diabetes, 2016);12 the Korea National Health and Nutrition Examination Survey (N = 1,341 with diabetes, 2010-2012);13 and the Joint Asia Diabetes Evaluation Registry (N = 3,415 with diabetes from China, 15,196 from Hong Kong, 3,714 from India, 1,651 from Korea, 3,365 from Philippines, 692 from Vietnam, and 78 from Taiwan, 2007-2012).14 See reference list at the end of this Appendix.  
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Appendix Table 1:  Estimates of absolute number of people aged 20-79 years old with T2DM for the years 2018 and 2030, by country, based on IDF estimates.15 95% confidence intervals are in parentheses. Monte Carlo sampling from the Gaussian distributions around these estimates was performed to incorporate the prevalence estimates into the outcome metrics. Classification of countries into regions is based on the International Standards Organization (ISO-3166) standard.  Country   Region  2018 2030  Afghanistan  Asia 1053371 (806706, 1519286) 1735972 (1315472, 2520914)  Albania  Europe 242142 (201328, 281372) 264658 (220480, 306960)  Algeria  Africa 1775544 (1182966, 2504770) 2443267 (1573364, 3432722)  Andorra  Europe 5899 (4841, 7776) 6629 (5412, 8665)  Angola  Africa 361802 (210879, 583250) 641394 (380636, 1059184)  Anguilla  Americas 1266 (980, 1558) 1523 (1148, 1842)  Antigua and Barbuda  Americas 8376 (7318, 9858) 10808 (9248, 12797)  Argentina  Americas 1728226 (1161169, 2535758) 2115204 (1471724, 3121943)  Armenia  Asia 163474 (106228, 270722) 175315 (111916, 314755)  Aruba  Americas 10905 (8659, 13926) 11379 (8904, 14484)  Australia  Oceania 1109756 (820101, 1367965) 1307034 (964216, 1612486)  Austria  Europe 578860 (482250, 746813) 670050 (544232, 812824)  Azerbaijan  Asia 475406 (308887, 771191) 568494 (364164, 1011771)  Bahamas  Americas 37195 (31945, 44455) 45120 (37604, 54011)  Bahrain  Asia 165463 (144834, 187189) 236962 (207196, 267498)  Bangladesh  Asia 6964460 (5381702, 10066385) 10331890 (7818844, 17844294)  Barbados  Americas 34519 (29181, 41139) 36271 (29824, 43810)  Belarus  Europe 465478 (379258, 995696) 463867 (379892, 936213)  Belgium  Europe 489465 (414227, 658096) 563199 (478336, 751277)  Belize  Americas 31641 (26298, 37442) 46333 (38600, 54549)  Benin  Africa 41138 (27585, 152265) 60019 (41092, 220249)  Bermuda  Americas 6403 (5210, 7700) 6226 (5028, 7442)  Bhutan  Asia 40351 (34021, 48669) 58819 (50240, 69588)  Bolivia (Plurinational State of)  Americas 391655 (306674, 620737) 563271 (442596, 891327)  Bosnia and Herzegovina  Europe 355029 (296772, 410643) 366553 (307572, 423014)  Botswana  Africa 53703 (30174, 89870) 89837 (44728, 146150)  Brazil  Americas 12483620 (10907665, 13871159) 17932750 (15509660, 20284592)  British Virgin Islands  Oceania 2793 (1942, 3784) 3428 (2288, 4636) 
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 Brunei Darussalam  Asia 40591 (32689, 50660) 51980 (40652, 64931)  Bulgaria  Europe 408496 (312315, 553814) 397173 (302744, 554026)  Burkina Faso  Africa 154901 (103508, 341589) 249268 (175916, 592128)  Burundi  Africa 137536 (96068, 275190) 249218 (148748, 601528)  Cabo Verde  Africa 6301 (4754, 16445) 9075 (7380, 25133)  Cambodia  Asia 247640 (226498, 278527) 368324 (336600, 417771)  Cameroon  Africa 685681 (545318, 861466) 1034476 (825916, 1290784)  Canada  Americas 2536461 (2310079, 3605333) 2828931 (2576316, 3963758)  Cayman Islands  Americas 5370 (4579, 6436) 6705 (5544, 8109)  Central African Republic  Africa 122645 (97436, 154276) 202814 (162116, 252807)  Chad  Africa 245711 (195223, 308843) 469930 (374724, 586747)  Channel Islands  ‘oceania 6840 (5834, 9097) 7741 (6516, 10507)  Chile  Americas 1194562 (968696, 1509074) 1635503 (1330040, 2052791)  China  Asia 111912900 (97135933, 146253900) 130175500 (113405864, 163337009)  China, Hong Kong SAR  Asia 620164 (521920, 742623) 697720 (587656, 836408)  China, Macao SAR  Asia 44487 (37526, 53735) 57699 (48672, 69515)  Colombia  Americas 2680858 (1832041, 3681089) 3915764 (3138500, 4758026)  Comoros  Africa 31660 (20932, 48879) 49815 (33100, 76002)  Congo  Africa 149839 (119415, 187887) 223649 (178028, 280019)  Cook Islands  Oceania 1526 (1043, 2442) 2589 (1528, 3594)  Costa Rica  Americas 314064 (261502, 374354) 387305 (314724, 463165)  Côte d'Ivoire  Africa 218019 (157070, 533761) 317909 (246028, 834944)  Croatia  Europe 210704 (152018, 447248) 202784 (147784, 443270)  Cuba  Americas 881872 (773338, 977614) 1070122 (920228, 1216624)  Curaçao  Americas 18196 (13672, 22260) 19535 (14896, 24104)  Cyprus  Asia 91566 (59824, 154812) 110522 (72808, 183985)  Czech Republic  Europe 746650 (528602, 992980) 815324 (597468, 1074245)  Dem. People's Republic of Korea  Asia 822711 (753318, 938325) 944538 (864208, 1093520)  Democratic Republic of the Congo  Africa 1765753 (1405219, 2216557) 3191200 (2542584, 3990432)  Denmark  Europe 375927 (310962, 435461) 408950 (336704, 472635)  Djibouti  Africa 39192 (28425, 59629) 52555 (34900, 83642)  Dominica  Americas 5902 (4660, 7566) 6893 (5380, 8785)  Dominican Republic  Americas 516104 (313894, 722264) 678949 (428264, 925164)  Ecuador  Americas 574084 (355057, 902437) 1042334 (739484, 1498838)  Egypt  Africa 8222605 (4172479, 9637605) 11675690 (5564772, 13742440)  El Salvador  Americas 327472 (271114, 433611) 404822 (312620, 552416)  Equatorial Guinea  Africa 31884 (25602, 39560) 46601 (37180, 58212) 
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 Eritrea  Africa 86550 (61018, 157127) 157878 (98492, 321711)  Estonia  Europe 53495 (36112, 105893) 55529 (37240, 107587)  Ethiopia  Africa 2544054 (1064246, 3978151) 3336534 (1757664, 6626130)  Faroe Islands  Europe 2397 (1821, 2953) 2668 (2032, 3340)  Fiji  Oceania 79510 (57164, 164640) 87198 (59204, 152327)  Finland  Europe 357470 (237031, 445504) 358451 (245340, 447932)  France  Europe 3181527 (2521002, 3990908) 3418907 (2682628, 4305015)  French Guiana  Americas 13385 (11701, 14857) 22770 (19520, 25869)  French Polynesia  Oceania 44039 (35138, 52807) 46547 (36948, 56133)  Gabon  Africa 66183 (52579, 83306) 96563 (76992, 120703)  Gambia  Africa 14746 (13658, 46662) 24599 (22768, 75804)  Georgia  Asia 225317 (150554, 368704) 235271 (152488, 413941)  Germany  Europe 7190853 (5588558, 8179664) 6899742 (5678424, 7954977)  Ghana  Africa 501145 (141788, 847598) 511924 (292124, 1154934)  Greece  Europe 563015 (434274, 1279596) 622950 (483484, 1319760)  Greenland  Americas 849 (718, 2386) 849 (718, 2386)  Grenada  Americas 6435 (4836, 8815) 8505 (6564, 11243)  Guadeloupe  Americas 52018 (40238, 63217) 56121 (43180, 68749)  Guam  Oceania 25422 (20412, 31784) 28715 (21924, 36479)  Guatemala  Americas 763886 (473673, 1164502) 1214721 (719884, 1832447)  Guinea  Africa 123083 (85569, 282608) 185116 (134140, 450028)  Guinea Bissau  Africa 18484 (13696, 46298) 26982 (20728, 69537)  Guyana  Americas 51156 (41715, 70268) 58466 (46160, 78326)  Haiti  Americas 350988 (222919, 621926) 493518 (319668, 1233958)  Honduras  Americas 293829 (198434, 489075) 510330 (369760, 745513)  Hungary  Europe 681856 (496396, 1228223) 679389 (486028, 1212655)  Iceland  Europe 17607 (11734, 22278) 20689 (14316, 26110)  India  Asia 72515680 (52780422, 91884372) 97984690 (73723892, 122943283)  Indonesia  Asia 10163610 (8389611, 11282555) 13129440 (10981832, 14695560)  Iran (Islamic Republic of)  Asia 4985973 (3696940, 6758239) 7085210 (5164852, 9596423)  Iraq  Asia 1434580 (971431, 1962382) 2304600 (1542348, 3093410)  Ireland  Europe 141008 (105672, 199628) 194527 (147192, 261218)  Israel  Asia 412470 (315486, 707880) 547151 (418148, 929804)  Italy  Europe 3306987 (2859446, 3951471) 3591734 (3115728, 4275263)  Jamaica  Americas 205859 (158151, 266600) 252008 (189212, 318552)  Japan  Asia 6950767 (5638516, 9349323) 6587593 (5347852, 8802972) 
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 Jordan  Asia 410733 (322997, 703945) 613262 (490512, 1039147)  Kazakhstan  Asia 799934 (524211, 1306241) 923920 (595472, 1664134)  Kenya  Africa 470785 (171369, 1779367) 806258 (422092, 3754071)  Kiribati  Oceania 12797 (6143, 17968) 15239 (9316, 20695)  Kuwait  Asia 444198 (370884, 535420) 668372 (520308, 923989)  Kyrgyzstan  Asia 218023 (146004, 341813) 276854 (184644, 518304)  Lao People's Democratic Republic  Asia 117111 (107077, 131677) 188192 (171968, 212187)  Latvia  Europe 98313 (75696, 126425) 97482 (74904, 124426)  Lebanon  Asia 570006 (442046, 717728) 631496 (493992, 791828)  Lesotho  Africa 30410 (17370, 52206) 44457 (26764, 74220)  Liberia  Africa 44374 (32937, 109938) 66648 (51052, 171580)  Libya  Africa 437317 (311660, 584694) 560971 (375812, 733194)  Liechtenstein  Europe 2747 (2224, 3049) 2828 (2416, 3168)  Lithuania  Europe 104959 (88282, 155223) 105609 (89256, 154040)  Luxembourg  Europe 24284 (15688, 43049) 30251 (19024, 52832)  Macedonia  Europe 183613 (152635, 213221) 200313 (167184, 231811)  Madagascar  Africa 383087 (242477, 632602) 662649 (397056, 1074326)  Malawi  Africa 204442 (123182, 363926) 390955 (233836, 655957)  Malaysia  Asia 3466658 (2959475, 4092486) 4621662 (3981568, 5390309)  Maldives  Asia 18534 (15510, 43272) 27637 (21904, 46345)  Mali  Africa 146026 (102960, 345065) 237180 (174864, 594194)  Malta  Europe 41073 (22387, 51804) 43882 (23976, 54975)  Marshall Islands  Oceania 10164 (6578, 13797) 9621 (6252, 12805)  Martinique  Americas 49261 (36674, 59706) 46920 (35388, 57433)  Mauritania  Africa 42990 (31600, 107666) 62440 (49240, 168657)  Mauritius  Africa 221730 (90222, 262526) 244800 (159088, 290294)  Mexico  Americas 11967890 (5741522, 14647724) 16274520 (8313900, 19977102)  Micronesia (Fed. States of)  Oceania 6123 (4406, 9030) 9310 (6720, 12960)  Moldova  Europe 187254 (148553, 264791) 234445 (191724, 321294)  Monaco  Europe 2131 (1716, 2609) 2337 (1884, 2914)  Mongolia  Asia 96291 (30782, 176701) 119723 (40588, 221205)  Montenegro  Europe 56089 (46628, 65102) 59024 (49196, 68310)  Montserrat  Americas 459 (402, 532) 524 (484, 620)  Morocco  Africa 1635004 (1231678, 2652294) 2241846 (1663352, 3484550)  Mozambique  Africa 300071 (192576, 541431) 511798 (303768, 935847)  Myanmar  Asia 1449515 (1038224, 2298843) 2643735 (1932512, 3837701)  Namibia  Africa 46147 (27030, 73564) 72560 (43600, 120216) 
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 Nauru  Oceania 1460 (1051, 1889) 1611 (1080, 2101)  Nepal  Asia 657108 (435670, 1369372) 931796 (640284, 2063810)  Netherlands  Europe 943684 (676032, 1284715) 1037266 (736944, 1333805)  New Caledonia  Oceania 44820 (33930, 56061) 47902 (38908, 57450)  New Zealand  Oceania 316454 (232706, 402682) 338123 (259884, 420853)  Nicaragua  Americas 367569 (233135, 515416) 454314 (319444, 631990)  Niger  Africa 170693 (107704, 337352) 275763 (175816, 603702)  Nigeria  Africa 1710470 (1199146, 4040407) 2516065 (1904492, 6480549)  Niue  Oceania 239 (145, 316) 214 (116, 306)  Norway  Europe 291620 (200209, 365860) 340100 (240044, 426634)  Oman  Asia 369448 (249552, 462541) 544860 (375984, 675942)  Pakistan  Asia 7503461 (5068829, 11156193) 10995720 (7639344, 16080949)  Palau  Oceania 2346 (1602, 5051) 3172 (1732, 6022)  Panama  Americas 217090 (169298, 273477) 321697 (266440, 380268)  Papua New Guinea  Oceania 634321 (278875, 888434) 837167 (530976, 1160104)  Paraguay  Americas 299785 (259903, 338162) 446715 (380940, 510164)  Peru  Americas 1133160 (804665, 1719635) 1636648 (1114620, 2588600)  Philippines  Asia 3701124 (2817893, 4796906) 5014895 (3728880, 6581034)  Poland  Europe 2165593 (1523183, 6214533) 2262371 (1604812, 5844306)  Portugal  Europe 1031139 (725206, 1310302) 1071754 (766572, 1346624)  Puerto Rico  Americas 387705 (308179, 474341) 401566 (317424, 492305)  Qatar  Asia 260928 (229414, 296874) 390418 (342492, 441609)  Republic of Korea  Asia 3394361 (2460310, 4369531) 3996904 (2934152, 5126737)  Réunion  Africa 107165 (77290, 129096) 122928 (90884, 162954)  Romania  Europe 1710243 (1045290, 2195755) 1559033 (919592, 2107770)  Russian Federation  Europe 8323771 (6150186, 11169173) 10296650 (5987504, 14328933)  Rwanda  Africa 213430 (123970, 354544) 420148 (252812, 791552)  Saint Kitts and Nevis  Americas 4931 (3415, 6945) 6084 (4212, 8557)  Saint Lucia  Americas 13939 (11368, 19314) 17232 (13648, 22873)  Saint Vincent and the Grenadines  Americas 8281 (6636, 11016) 10028 (7884, 12999)  Samoa  Oceania 7268 (4966, 16412) 8672 (5820, 20312)  San Marino  Europe 2033 (1667, 2397) 2345 (1912, 2763)  Sao Tome and Principe  Africa 1762 (1317, 4560) 2643 (2104, 7365)  Saudi Arabia  Asia 3851964 (2954474, 4427450) 5469494 (4091752, 6280745)  Senegal  Africa 137876 (94233, 321353) 221791 (163420, 561438)  Serbia  Europe 828088 (690590, 958688) 819075 (684648, 946715) 
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 Seychelles  Africa 7640 (5501, 10600) 12474 (7920, 16860)  Sierra Leone  Africa 60130 (42418, 139974) 87706 (64244, 213367)  Singapore  Asia 593076 (492114, 685353) 692618 (569140, 805408)  Sint Maarten (Dutch part)  Americas 3495 (2974, 4192) 4326 (3560, 5200)  Slovakia  Europe 396253 (236205, 475762) 451771 (261424, 537988)  Slovenia  Europe 156974 (100130, 207361) 169676 (104076, 222991)  Solomon Islands  Oceania 43077 (22953, 65124) 62058 (36076, 93538)  Somalia  Africa 222422 (158073, 374171) 386390 (244276, 708242)  South Africa  Africa 1829207 (1014950, 3729624) 2633569 (1367424, 5259500)  South Sudan  Africa 433982 (310884, 579605) 645568 (456804, 857835)  Spain  Europe 3497947 (2621566, 5015841) 3964455 (2929116, 5663136)  Sri Lanka  Asia 1168936 (791970, 1819035) 1322407 (882028, 2060194)  State of Palestine  Asia 172415 (104868, 364354) 286916 (158268, 610090)  Sudan  Africa 2218476 (1089710, 3758088) 2819352 (1451136, 5413432)  Suriname  Americas 44747 (29465, 89601) 52974 (38484, 82308)  Swaziland  Africa 17008 (9794, 29913) 23890 (14388, 40543)  Sweden  Europe 482449 (392324, 653875) 490056 (389996, 715770)  Switzerland  Europe 459769 (432382, 684840) 541227 (503700, 748367)  Syrian Arab Republic  Asia 726032 (547335, 996339) 1266416 (962324, 1724851)  Taiwan  Asia 1904876 (1362021, 2516152) 2090333 (1509376, 2722720)  Tajikistan  Asia 266955 (179299, 410837) 372998 (251064, 691050)  Thailand  Asia 4106930 (2998277, 4839127) 4654619 (3261984, 5423349)  Timor-Leste  Asia 32923 (27522, 38308) 47021 (40612, 53809)  Togo  Africa 172842 (49037, 278306) 253791 (78192, 408005)  Tokelau  Oceania 206 (110, 273) 252 (100, 340)  Tonga  Oceania 7129 (4649, 11318) 8609 (6228, 13838)  Trinidad and Tobago  Americas 115823 (91386, 157592) 145971 (121328, 181037)  Tunisia  Africa 751936 (563012, 1137407) 948897 (631676, 1366639)  Turkey  Asia 6625234 (5664827, 8081333) 8606189 (7377472, 10455463)  Turkmenistan  Asia 208272 (133923, 339282) 269369 (172880, 485995)  Tuvalu  Oceania 1697 (956, 2210) 1561 (836, 2354)  Uganda  Africa 297550 (165203, 674855) 867422 (494512, 2022548)  Ukraine  Europe 2729566 (1770750, 4692247) 2639892 (1687936, 4777706)  United Arab Emirates  Asia 1186784 (1005931, 1415700) 1699868 (1429464, 2034054)  United Kingdom  Europe 2682726 (2288142, 3600088) 3056956 (2574424, 4210151)  United Republic of Tanzania  Africa 939479 (578124, 2090382) 1826426 (1129524, 3882806) 
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 United States of America  Americas 29338180 (26690902, 31679401) 31825320 (28715312, 34490266)  United States Virgin Islands  Oceania 11811 (9450, 14098) 11106 (8912, 13266)  Uruguay  Americas 149073 (118525, 196662) 168875 (125384, 261274)  Uzbekistan  Asia 1220580 (680900, 2050170) 1550373 (919460, 2841012)  Vanuatu  Oceania 16776 (12277, 25124) 30838 (22040, 42794)  Venezuela (Bolivarian Republic of)  Americas 1369611 (1021586, 1905704) 2618469 (2032188, 3329925)  Viet Nam  Asia 3520101 (2736766, 4858207) 4818023 (3490424, 7353720)  Western Sahara  Africa 9552 (8184, 25873) 12658 (10896, 36979)  Yemen  Asia 543920 (401731, 1001477) 927772 (694008, 1597533)  Zambia  Africa 230349 (132762, 377875) 423312 (252392, 703175)  Zimbabwe  Africa 114253 (70434, 467417) 334696 (202784, 668168)  
Appendix Page 8 of 23 
 Appendix Table 2:   (A) RECODe equations used to estimate rates of microvascular complications of T2DM. The 10-year risk of an outcome can be computed as 1- lambda^exp(sum(beta*x) – mean(sum(beta*x))), where beta are the equation coefficients and x are the values for each covariate for an individual patient within the cohort under study. Lambda values were 0.973 for renal failure/ESRD, 0.921 for vision loss, and 0.870 for loss of pressure sensation. After the equations’ baseline hazard rates were recalibrated to match DALY estimates from the Global Burden of Disease project for each complication (see GBD website for cause-specific DALY estimates),22 the mean(sum(beta*x)) values were 1.37 for renal failure, 130.9 for severe vision loss, and 4.99 for pressure sensation loss. To estimate the reduction in risk with treatment, we used estimates from a prior systematic review, in which the risks were first converted to rates (where initial rate = -ln(1-risk)/10, then calculated the new reduced rate of each treatment as (initial rate * (new A1c/initial A1c)b), where b is 1.14 for renal failure, 1.29 for severe vision loss , and 1.19 for pressure sensation loss.4 The new A1c was calculated from initial A1c as noted in the main text, by using values from a meta-analysis to estimate reduction with each treatment (typically 1-2% reduction with each oral medication, then reduction to target A1c level with insulin instead of sulfonylurea if necessary).17 Blank cells indicate that the particular covariate is not included in the given equation (a beta coefficient of zero).  Covariate Renal failure/end-stage renal disease Severe vision loss Pressure sensation loss Age, years  –0.01938 0.02285 0.03022 
Women  –0.01129 0.2264 –0.18680 
Black  0.08812 –0.16770 –0.09448 Hispanic or Latino  0.2338 - - 
Tobacco smoking, current  0.1483 - - Systolic blood pressure, mm Hg  0.00303 0.00824 0.00456 Cardiovascular disease history  –0.02164 0.1127 0.26672 Blood pressure- –0.07952 0.06393 0.18192 
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lowering drugs  Oral diabetes drugs  –0.12560 –0.23490 –0.25747 Anticoagulants  0.03199   
HbA1c, %  0.1369 0.1449 0.18866 
Total cholesterol, mg/dL  –0.00111 –0.00017 0.00219 HDL cholesterol, mg/dL  0.00629 0.00545 –0.00539 Serum creatinine, mg/dL  0.8609 0.6947 0.60442 Urine albumin:creatinine ratio, mg/g 0.00036 0.0002 -    (B) Hypoglycaemia risk equation. The risk equation was developed from the ACCORD study sample (N = 10,251),16 using elastic net regularization17 for parameter selection and refitting to avoid imprecise standard errors. The logistic regression equation estimates 5-year probability of hypoglycaemia requiring medical assistance. The risk equation was estimated through 5-fold cross-validation using individual participant data from the ACCORD trial. The equation had a C-statistic of 0.76, and passed the Hosmer-Lemeshow test for calibration.18 To calculate the probability of a hypoglycemic event requiring medical assistance, an individual’s value for each covariate is multiplied by the coefficient then added to the intercept to derive a sum of terms, then the 5-year probability of a major hypoglycaemic event equals 1/(1+exp(-sum of terms)).  Covariate Coefficient Standard Error Wald Z score P value Intercept -8.8533 3.0621 -2.89 0.0038 Age, years 0.0136 0.0274 0.50 0.6190 Female  0.2835 0.3580 0.79 0.4284 Starting haemoglobin A1c value, % 0.6870 0.2184 3.15 0.0017 Change in haemoglobin A1c with therapy, % 0.1323 0.1593 0.83 0.4063 Systolic blood pressure, mmHg -0.0026 0.0098 -0.26 0.7924 Alanine aminotransferase, mg/dL -0.0472 0.0195 -2.42 0.0157 Loss of foot vibratory sensation  0.5126 0.4702 1.09 0.2757 Units of insulin per day 0.0005 0.0046 0.12 0.9080 
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On sulfonylurea  -0.3323 0.4269 -0.78 0.4363 Severe vision loss  0.0226 0.3919 0.06 0.9540 Serum creatinine, mg/dL 1.1783 0.7396 1.59 0.1112 Time since diabetes diagnosis, years 0.0391 0.0226 1.73 0.0844     
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Appendix Table 3:  Disability weights used for estimating DALYs averted through insulin treatment, based on a prior global survey and systematic review.19   Disease outcome Utility value (95% CI) Renal failure/end-stage renal disease 0.573 (0.397, 0.749) Severe vision loss 0.191 (0.129, 0.269) Pressure sensation loss 0.099 (0.066, 0.145) Hypoglycaemia requiring medical attention 0.054 (0.033, 0.084) Daily finger sticks and injections 0.009 (0.004, 0.018)  
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Appendix Table 4:  Numerical values corresponding to main text Figure 2. 95% confidence intervals are listed in parentheses.  (A) People with type 2 diabetes mellitus estimated to use insulin   Base case (7%) Intensive (6.5%) Liberal (8%) Age-tailored (7% (<75yo), 8% (>75yo)) Risk based (<5% risk) Africa 5119862 (2999782, 8733785) 7112791 (4167460, 12133449) 2818170 (1651196, 4807412) 4544439 (2662636, 7752192) 7112791 (4167460, 12133449) Americas 17272413 (13595462, 20657257) 23995776 (18887556, 28698186) 9507403 (7483467, 11370552) 15331161(12067463, 18335581) 23995776 (18887556, 28698186) Asia 47558556 (38157723, 61597425) 66070932 (53010784, 85574492) 26178065 (21003483, 33905600) 4221343 (33869163, 54674469) 66070932 (53010784, 85574492) Europe 8523506 (6240663, 12033426) 11841319 (8669869, 16717489) 4691667 (3435102, 6623662) 7565546 (5539273, 10680985) 11841319 (8669869, 16717489) Oceania 518356 (370282, 671140) 720129 (514416, 932385) 285323 (203818, 369422) 460098 (328666, 595711) 720129 (514416, 932385)   (B) Number of U100 insulin vials (1000 units each) used per year  Base case (7%) Intensive (6.5%) Liberal (8%) Age-tailored (7% (<75yo), 8% (>75yo)) Risk based (<5% risk) Africa 87651814 (50501623, 144857489) 121770667 (70159601, 201243902) 48246941 (27798042, 79735153) 77800596 (44825728, 128576905) 121770667 (70159601, 201243902) Americas 323833311 (257426785, 383481167) 449886847 (357631290, 532752893) 178250353 (141697638, 211082835) 287437572 (228494498, 340381584) 449886847 (357631290, 532752893) Asia 725118538 (585106758, 937297246) 1007374109 (812862130, 1302144310) 399133230 (322065343, 515924581) 643622211 (519346404, 831954080) 1007374109 (812862130, 1302144310) Europe 167389188 (122645636, 236554000) 232546164 (170385988, 328633682) 92137470 (67508892, 130208452) 148576258 (108861450, 209967613) 232546164 (170385988, 328633682) Oceania 9900809 (7098276, 12781196) 13754743 (9861312, 17756333) 5449788 (3907165, 7035264) 8788054 (6300498, 11344713) 13754743 (9861312, 17756333)  
Appendix Page 13 of 23 
 (C) Net DALYs averted by insulin treatment  Base case (7%) Intensive (6.5%) Liberal (8%) Age-tailored (7% (<75yo), 8% (>75yo)) Risk based (<5% risk) Africa 26585 (15532, 45613) 19091 (11154, 32755) 33817 (19757, 58020) 38337 (22397, 65774) 33471 (19555, 57426) Americas 58216 (45933, 69554) 41806 (32985, 49948) 74051 (58428, 88474) 83948 (66237, 100298) 73293 (57830, 87569) Asia 215179 (172646, 277939) 154524 (123981, 199593) 273711 (219609, 353543) 310291 (248959, 400793) 270909 (217360, 349923) Europe 29282 (21192, 41539) 21028 (15218, 29830) 37247 (26956, 52839) 42225 (30559, 59901) 36865 (26680, 52298) Oceania 1839 (1298, 2408) 1321 (932, 1729) 2339 (1652, 3063) 2652 (1873, 3472) 2315 (1635, 3031)   (D) Ratio of DALYS averted by prevention of microvascular events with insulin treatment, versus from DALYs induced by insulin treatment (including hypoglycaemia requiring medication attention, daily finger sticks, and injections), worldwide. Target A1c = 7% Target A1c = 6.5% Target A1c = 8% Target A1c = 7% (<75yo), =8% (>75yo) Target risk <5% 2.0 (1.4, 3.4) 1.5 (1.1, 2.6) 6.0 (4.2, 10.2) 4.3 (3.0, 7.4) 6.0 (4.2, 10.2)  
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Appendix Figure 1:  Proportion of people with T2DM who would receive insulin if targeting A1c of 7% after maximum oral therapy, if insulin were widely available.  
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Appendix Figure 2:  Variations in insulin treatment and DALYs averted under alternative treatment targets in the year 2024. All estimates are made with the approach defined in the Methods section that accounted for both demographic change and increased insulin access. The height of the bars reflects the mean, and error bars reflect 95% confidence intervals.  (A) People with type 2 diabetes mellitus estimated to use insulin  
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  (B) Number of U100 insulin vials (1000 units each) used per year   
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 (C) Net DALYs averted by insulin treatment  
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(D) Ratio of DALYS averted by prevention of microvascular events with insulin treatment, versus from DALYs induced by insulin treatment (including hypoglycaemia requiring medication attention, daily finger sticks, and injections), worldwide.    
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